TITLE

COAGULATION CHANGES DURING MIGRAINE

AUTHOR(S)
Sicuteri, F.; Michelacci, S.; Lombardi, V.; Franchi, G.
PUB. DATE
December 1963
SOURCE
Angiology;Dec1963, Vol. 14 Issue 12, p580
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
During migraine attacks, thromboelastographic changes indicating blood hypocoagulability occur in the patient. It is possible that blood hypocoagulability, seen during the migraine attack, is due to greater production of heparin by mast cells. These studies stemmed from the hypothesis that some active substances play an important role in the pathogenesis of migraine. Some of these substances are present within tissue mast cells, which also contain hepain.
ACCESSION #
16398249

 

Related Articles

  • THE EFFECT OF INTRAVENOUS HEPARIN AND MEPESULFATE� ON CHOLESTEROL PARTITION AND THE LIPOPROTEIN PATTERN. Moses, Campbell // Angiology;Aug1954, Vol. 5 Issue 4, p312 

    The effects of a single intravenous injection of 100 mg sodium heparin or 150 mg of Mepesulfate� were studied in 6 male subjects. The Mepesulfate� produced little consistent effect on the coagulation time but distinctly increased the prothrombin time. Neither anticoagulant altered the...

  • Treatment with Bivalirudin (Hirulog) as Compared with Heparin during Coronary Angioplasty for Unstable or Postinfarction Angina. Bittl, John A.; Strony, John; Brinker, Jeffrey A.; Ahmed, Waqar H.; Meckel, Clyde R.; Chaitman, Bernard R.; Deutsch, Ezra; Adelman, Burt // New England Journal of Medicine;9/21/95, Vol. 333 Issue 12, p764 

    Background: Heparin is often administered during and after coronary angioplasty to prevent closure of the dilated vessel. However, ischemic or hemorrhagic complications occur in 5 to 10 percent of treated patients. We studied whether these complications could be prevented when the direct...

  • THROMBOELASTOGRAPHY. Toledo, F. B.; Milanéz-López, B. // Angiology;Apr1958, Vol. 9 Issue 2, p88 

    Examines the utility of thromboelastography in the study of vascular diseases. Schematic description of the thromboelastograph; Ability of thromboelastography to diagnose increases in coagulation and the difference between thrombosis and hemorrhage; Usefulness of the procedure in determining...

  • epoprostenol.  // Royal Society of Medicine: Medicines;2002, p231 

    The article presents information on epoprostenol, a prostaglandin present naturally in the walls of blood vessels. When administered therapeutically by intravenous infusion it has antiplatelet or antithrombotic activity and so inhibits blood coagulation by preventing the aggregation of...

  • Differential Effects of Unfractionated Heparin and Low-Molecular-Weight Heparins on Tissue Thromboplastin Inhibition Test. Gerbutavicius, Rolandas; Iqbal, Omer; Messmore, Harry; Hoppensteadt, Debra A.; Demir, Muzaffer; Khan, Erum; Bacher, Peter; Fareed, Jawed // Clinical & Applied Thrombosis/Hemostasis;Oct2000, Vol. 6 Issue 4, p190 

    Circulating anticoagulants are endogenously produced substances that interfere with in vitro tests of coagulation like activated partial thromboplastin time (APTT). and cause prolongation of the clotting times. Evaluation of the abnormal APTT involving various factor assays and mixing studies...

  • aPTT in Heparinized Patients: Influence of the Interval Between Sampling and Testing. Rachakonda, Vikrant; Rachakonda, Leelanand; Belliveau, Robert R. // Clinical & Applied Thrombosis/Hemostasis;Jul1998, Vol. 4 Issue 3, p213 

    Activated partial thromboplastin times(aPTTs) from, 29 whole blood samples were drawn from patients receiving unfractionated heparin through a constant intravenous drip. Three aPTTs were determined for each whole blood sample. The first aPTT was performed on a separate portion of the original...

  • Perioperative Low-Molecular-Weight Heparin and Neuraxial Anesthesia: A Review of Current Practice Guidelines. Cannavo, Dominick; Friedman, Richard J. // Internet Journal of Anesthesiology;2003, Vol. 6 Issue 2, p57 

    Over the past nine years, the wide acceptance of low-molecular-weight heparins (LMWHs) in the United States has been the result of this class of drugs excellent safety and efficacy profile across multiple applications to prevent and treat arterial and venous thromboembolic disease. There has...

  • Hemorrhagic Complications in Patients Treated with Anticoagulant Doses of a Low Molecular Weight Heparin (Enoxaparin) in Routine Hospital Practice. Ellis, Martin H.; Hadari, Ruth; Tchuvrero, Noa; Shapira, Shirley; Kovlenko, Irena; Kozmìakova, Mariana; Zissin, Rivka; Elis, Avishay // Clinical & Applied Thrombosis/Hemostasis;Apr2006, Vol. 12 Issue 2, p199 

    Low molecular weight heparins (LMWHs) are a rapidly growing class of anticoagulant drug. Their efficacy has been demonstrated in several clinical settings where they are rapidly becoming the anticoagulant of choice. Controlled clinical studies in patients with deep vein thrombosis, pulmonary...

  • Thrombosis during off pump LVAD placement in a patient with heparin induced thrombocytopenia using bivalirudin. Awad, Hamdy; Bryant, Richard; Malik, Obaid; Dimitrova, Galina; Sai-Sudhakar, Chittoor Bhaskar // Journal of Cardiothoracic Surgery;2013, Vol. 8 Issue 1, p1 

    Here we present our attempt at off pump HeartMate II left ventricular assist device (LVAD) implantation using the anticoagulant bivalirudin in a patient with heparin induced thrombocytopenia, which resulted in thrombosis within the LVAD device. This required that our procedure be converted to on...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics